Ljunggren H G, Pääbo S, Cochet M, Kling G, Kourilsky P, Kärre K
Department of Tumor Biology, Karolinska Institutet, Stockholm, Sweden.
J Immunol. 1989 Apr 15;142(8):2911-7.
It has previously been reported that MHC class I-deficient RBL-5 and YAC-1 lymphoma sublines show an enhanced NK sensitivity in vitro. In the present study such lymphoma variants were found to have different defects in H-2 biosynthesis such as 1) reduced beta 2-microglobulin and H-2 H chain transcription, 2) block in beta 2-microglobulin translation, and 3) impaired association between beta 2-microglobulin and H-2 H chains. For lines with the latter two defects, the results suggested that a major part of the H chains were arrested before the middle Golgi complex as indicated by their failure to undergo carbohydrate side chain trimming. The data suggest that NK sensitivity can be directly influenced by the membrane expression of MHC class I gene products of tumor targets because three independent molecular defects, all interfering with the cell surface H-2 expression, gave rise to NK-sensitive phenotypes. These variant lines will also be useful tools for studies of H-2 glycoprotein assembly and transport and for Ag presentation to CTL.
此前有报道称,缺乏MHC I类分子的RBL - 5和YAC - 1淋巴瘤亚系在体外表现出增强的NK敏感性。在本研究中,发现此类淋巴瘤变体在H - 2生物合成方面存在不同缺陷,例如:1)β2-微球蛋白和H - 2重链转录减少;2)β2-微球蛋白翻译受阻;3)β2-微球蛋白与H - 2重链之间的结合受损。对于具有后两种缺陷的细胞系,结果表明,如重链未能进行碳水化合物侧链修剪所示,大部分重链在高尔基复合体中部之前就被阻滞。数据表明,NK敏感性可直接受肿瘤靶标MHC I类基因产物的膜表达影响,因为三种独立的分子缺陷均干扰细胞表面H - 2表达,从而产生了NK敏感表型。这些变体细胞系也将成为研究H - 2糖蛋白组装与运输以及抗原呈递给CTL的有用工具。